Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
Status Of AI Regulation On Drug Development
As AI capabilities scale, the FDA expects sponsors and their outsourcing partners to treat AI like any other regulated, computerized system that can influence safety, effectiveness, or quality–define the role, document credibility, control the lifecycle, and monitor performance. read more
Sustaining the Future of Life Science Product Research
Few people say it outright, but the integrity of stored research and clinical samples underpins all scientific and medical progress. Every breakthrough drug, advanced therapy, or medical device depends on millions of biological, chemical, and physical samples that must be preserved intact across the entire product lifecycle. read more
Why DSCSA Compliance in 2026 Hinges on Execution, Not Implementation
After a decade of ramp-up, the era of DSCSA enforcement is no longer theoretical — it’s here. But as we move deeper into this phase of full compliance, the real story unfolds not just in establishing data feeds, but in the operational cracks that persist behind the scenes. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Made Scientific and Regenicin Partner to Advance NovaDerm Toward FDA Product Approval
Wednesday, April 22, 2026
Made Scientific and Regenicin announced a manufacturing relationship to advance NovaDerm, an autologous cultured skin substitute for severe burns and ... read more
INTERPHEX 2026 Exhibitor Awards Honor Breakthrough Bioprocessing, Containment, and Cleanroom Technologies
Tuesday, April 21, 2026
The 2026 INTERPHEX Exhibitor Awards recognize innovative technologies that advance pharmaceutical and biopharmaceutical manufacturing, from cell ... read more
Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Demand for MRD Solutions
Monday, April 20, 2026
Integrated DNA Technologies (IDT), a Danaher company, announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment ... read more
Eurofins CDMO Alphora Integrates Advanced Continuous Flow Technology in API Manufacturing
Thursday, April 16, 2026
Eurofins CDMO Alphora announced the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of ... read more
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
Thursday, April 16, 2026
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services announced a strategic collaboration under which Piramal will refer applicable customers ... read more